Fecal Microbiota Transplantation for Fibromyalgia: A Case Report and Review of the Literature — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Fecal Microbiota Transplantation for Fibromyalgia: A Case Report and Review of the Literature
The Bacteriotherapy Clinic, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Institute of Rheumatology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Department of Medicine H, Soroka Medical Center, Beer Sheva, Israel
,
The Bacteriotherapy Clinic, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
1 The Bacteriotherapy Clinic, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2 Institute of Rheumatology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3 Department of Medicine H, Soroka Medical Center, Beer Sheva, Israel
4 The Bacteriotherapy Clinic, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
5 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
A 58-year-old patient diagnosed with fibromyalgia, irritable bowel syndrome (IBS) and chronic fatigue syndrome (CFS), non-responsive to variety of treatments over the years, suffered from significant social and occupational disabilities. The patient was interested in fecal microbiota transplantation (FMT), but given that FMT is not approved for these indications, he used an online protocol for FMT screening and preparation and self-instilled the filtrate using an enema 6 times. FMT resulted in a gradual improvement of symptoms and 9 months after the last treatment, the patient reported full recovery of symptoms, going back to work at full time employment. Improvement of symptoms was associated with major alterations of the enteric microbiota, according to next generation sequencing analysis performed before the first FMT and after the last FMT. Most prominent alterations at the genus level included a decrease in fecal Streptococcus proportion from 26.39% to 0.15% and an increase in Bifidobacterium from 0% to 5.23%. This case is added to several additional case reports that demonstrated the effectivity of FMT in these functional disorders that are lacking an otherwise good medical therapeutic intervention. We conclude that randomized controlled trials are required to ground FMT as a possible therapy for these difficult-to-treat conditions.
Queiroz, L.P. (2013) Worldwide Epidemiology of Fibromyalgia. Current Pain and Headache Reports, 17, 356.
Fietta, P. and Manganelli, P. (2007) Fibromyalgia and Psychiatric Disorders. Acta Biomed, 78, 88-95.
Macfarlane, G.J., et al. (2016) EULAR Revised Recommendations for the Management of Fibromyalgia. Annals of the Rheumatic Diseases, 76, 318-328.
Rimbaut, S., Van Gutte, C., Van Brabander, L. and Vanden Bossche, L. (2016) Chronic Fatigue Syndrome—An Update. Acta Clinica Belgica, 71, 273-280.
Harvey, S.B. and Wessely, S. (2009) Chronic Fatigue Syndrome: Identifying Zebras amongst the Horses. BMC Medicine, 7, 58.
Mearin, F., et al. (2016) Bowel Disorders. Gastroenterology, 150, 1393-1407.e5.
Quigley, E.M., et al. (2016) World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome: A Global Perspective Update September 2015. Journal of Clinical Gastroenterology, 50, 704-713. https://doi.org/10.1097/MCG.0000000000000653
Albrecht, P.J. and Rice, F.L. (2016) Fibromyalgia Syndrome Pathology and Environmental Influences on Afflictions with Medically Unexplained Symptoms. Reviews on Environmental Health, 31, 281-294. https://doi.org/10.1515/reveh-2015-0040
Veale, D., et al. (1991) Primary Fibromyalgia and the Irritable Bowel Syndrome: Different Expressions of a Common Pathogenetic Process. British Journal of Rheumatology, 30, 220-222. https://doi.org/10.1093/rheumatology/30.3.220
Sivri, A., et al. (1996) Bowel Dysfunction and Irritable Bowel Syndrome in Fibromyalgia Patients. Clinical Rheumatology, 15, 283-286. https://doi.org/10.1007/BF02229708
Aaron, L.A., Burke, M.M. and Buchwald, D. (2000) Overlapping Conditions among Patients with Chronic Fatigue Syndrome, Fibromyalgia, and Temporomandibular Disorder. Archives of Internal Medicine, 160, 221-227. https://doi.org/10.1001/archinte.160.2.221
Xu, M.Q., et al. (2015) Fecal Microbiota Transplantation Broadening Its Application beyond Intestinal Disorders. World Journal of Gastroenterology, 21, 102-111. https://doi.org/10.3748/wjg.v21.i1.102
Nagel, R., et al. (2016) Comparison of Faecal Microbiota in Blastocystis-Positive and Blastocystis-Negative Irritable Bowel Syndrome Patients. Microbiome, 4, 47.
Wallace, D.J. and Hallegua, D.S. (2004) Fibromyalgia: The Gastrointestinal Link. Current Pain and Headache Reports, 8, 364-368. https://doi.org/10.1007/s11916-996-0009-z
Giloteaux, L., et al. (2016) Reduced Diversity and Altered Composition of the Gut Microbiome in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Microbiome, 4, 30.
Zhang, Y., et al. (2016) Effects of Probiotic Type, Dose and Treatment Duration on Irritable Bowel Syndrome Diagnosed by Rome III Criteria: A Meta-Analysis. BMC Gastroenterology, 16, 62.
Lembo, A., et al. (2016) Repeat Treatment with Rifaximin Is Safe and Effective in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology, 151, 1113-1121.
Youngster, I., et al. (2014) Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection Using a Frozen Inoculum from Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study. Clinical Infectious Diseases, 58, 1515-1522. https://doi.org/10.1093/cid/ciu135
Debast, S.B., Bauer, M.P. and Kuijper, E.J. (2014) European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium Difficile Infection. Clinical Microbiology and Infection, 20, 1-26.
Surawicz, C.M., et al. (2013) Guidelines for Diagnosis, Treatment, and Prevention of Clostridium Difficile Infections. The American Journal of Gastroenterology, 108, 478-498.
Moayyedi, P., et al. (2015) Fecal Microbiota Transplantation Induces Remission in Patients with Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology, 149, 102-109.
Ananthaswamy, A. (2011) Faecal Transplant Eases Symptoms of Parkinson’s. New Scientist, 209, 8-9.
Borody, T.J., Rosen, D.M., Torres, M., Campbell, J. and Nowak, A. (2011) Myoclonus-Dystonia (M-D) Mediated by GI Microbiota Diarrhoea Treatment Improves M-D Symptoms. The American Journal of Gastroenterology, 106, S352.
Borody, T.J., Leis, L.S., Campbell, J., et al. (2011) Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis (MS). The American Journal of Gastroenterology, 106, S352.
Vrieze, A., et al. (2012) Transfer of Intestinal Microbiota from Lean Donors Increases Insulin Sensitivity in Individuals with Metabolic Syndrome. Gastroenterology, 143, 913-916.
Borody, T.J., Nowak, A. and Finlayson, S. (2012) The GI Microbiome and Its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy. Journal of the Australasian College of Nutritional and Environmental Medicine, 31, 3-8.
Pinn, D.M., Aroniadis, O.C. and Brandt, L.J. (2014) Is Fecal Microbiota Transplantation the Answer for Irritable Bowel Syndrome? A Single-Center Experience. The American Journal of Gastroenterology, 109, 1831-1832. https://doi.org/10.1038/ajg.2014.295
Sheedy, J.R., et al. (2009) Increased d-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome. In Vivo, 23, 621-628.
Sokol, H., et al. (2008) Faecalibacterium Prausnitzii Is an Anti-Inflammatory Commensal Bacterium Identified by Gut Microbiota Analysis of Crohn Disease Patients. Proceedings of the National Academy of Sciences, 105, 16731-16736. https://doi.org/10.1073/pnas.0804812105
Furrie, E., et al. (2005) Synbiotic Therapy (Bifidobacterium Longum/Synergy 1) Initiates Resolution of Inflammation in Patients with Active Ulcerative Colitis: A Randomised Controlled Pilot Trial. Gut, 54, 242-249. https://doi.org/10.1136/gut.2004.044834
Groeger, D., et al. (2013) Bifidobacterium Infantis 35624 Modulates Host Inflammatory Processes beyond the Gut. Gut Microbes, 4, 325-339. https://doi.org/10.4161/gmic.25487
Evengard, B., et al. (2007) Increased Number of Candida Albicans in the Faecal Microflora of Chronic Fatigue Syndrome Patients during the Acute Phase of Illness. Scandinavian Journal of Gastroenterology, 42, 1514-1515. https://doi.org/10.1080/00365520701580397
Wang, Z.K., et al. (2014) Intestinal Microbiota Pathogenesis and Fecal Microbiota Transplantation for Inflammatory Bowel Disease. World Journal of Gastroenterology, 20, 14805-14820. https://doi.org/10.3748/wjg.v20.i40.14805
Kelly, C.R., et al. (2015) Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology, 149, 223-237. https://doi.org/10.1053/j.gastro.2015.05.008
Choi, H.H. and Cho, Y.S. (2016) Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clinical Endoscopy, 49, 257-265. https://doi.org/10.5946/ce.2015.117
El-Matary, W. (2013) Fecal Microbiota Transplantation: Long-Term Safety Issues. The American Journal of Gastroenterology, 108, 1537-1538. https://doi.org/10.1038/ajg.2013.208
Hohmann, E.L., Ananthakrishnan, A.N. and Deshpande, V. (2014) Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-Year-Old Man with Ulcerative Colitis and Bloody Diarrhea. The New England Journal of Medicine, 371, 668-675. https://doi.org/10.1056/NEJMcpc1400842